HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder Upbeat About Clinique, While Namesake Shows ‘Big Brands Can Grow Fast’

This article was originally published in The Rose Sheet

Executive Summary

Driven by Estee Lauder and Clinique, the firm achieved gains in North America in fiscal 2018, despite continued brick-and-mortar retail erosion, while capitalizing on China’s growing appetite for luxury beauty. In a call with analysts, CEO Freda provided a succinct update on the company’s review of potentially flawed product claims, an issue raised last quarter that now is expected not to be material.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121792

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel